SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.442
AS - Asia 8.047
EU - Europa 4.094
SA - Sud America 1.143
AF - Africa 201
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 14
Totale 27.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.175
SG - Singapore 3.224
CN - Cina 2.062
BR - Brasile 909
VN - Vietnam 886
IT - Italia 669
DE - Germania 649
UA - Ucraina 631
HK - Hong Kong 618
GB - Regno Unito 499
TR - Turchia 416
FI - Finlandia 346
PL - Polonia 320
FR - Francia 242
SE - Svezia 198
JP - Giappone 192
RU - Federazione Russa 190
IN - India 146
CA - Canada 130
MX - Messico 104
ID - Indonesia 92
BD - Bangladesh 85
ZA - Sudafrica 76
AR - Argentina 70
IQ - Iraq 65
BE - Belgio 57
NL - Olanda 56
AT - Austria 53
CO - Colombia 44
PK - Pakistan 39
MA - Marocco 36
ES - Italia 34
CZ - Repubblica Ceca 33
EC - Ecuador 32
LT - Lituania 26
UZ - Uzbekistan 26
SA - Arabia Saudita 25
VE - Venezuela 25
PY - Paraguay 20
PH - Filippine 18
IR - Iran 17
CL - Cile 16
ET - Etiopia 16
KE - Kenya 16
MY - Malesia 16
AE - Emirati Arabi Uniti 15
AU - Australia 14
EG - Egitto 13
NP - Nepal 13
DZ - Algeria 12
UY - Uruguay 12
IE - Irlanda 10
NO - Norvegia 10
PE - Perù 10
PT - Portogallo 10
JO - Giordania 9
RO - Romania 9
TN - Tunisia 9
AZ - Azerbaigian 8
KR - Corea 8
KZ - Kazakistan 8
LB - Libano 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AL - Albania 6
BG - Bulgaria 6
CH - Svizzera 6
EU - Europa 6
IL - Israele 6
JM - Giamaica 6
NG - Nigeria 6
OM - Oman 6
AO - Angola 5
GR - Grecia 5
HN - Honduras 5
HR - Croazia 5
GE - Georgia 4
MN - Mongolia 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
CY - Cipro 2
GD - Grenada 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
Totale 27.929
Salva come PNG Salva come JPEG
Città #
Singapore 1.979
Ashburn 1.717
Woodbridge 1.339
Fairfield 1.093
San Jose 1.046
Chandler 768
Houston 735
Jacksonville 679
Beijing 649
Santa Clara 628
Hong Kong 609
Ann Arbor 561
Wilmington 395
Seattle 386
Cambridge 360
Warsaw 306
Ho Chi Minh City 295
New York 260
Los Angeles 253
Izmir 236
Nanjing 219
Dallas 215
Ferrara 198
Hanoi 194
Tokyo 189
Princeton 180
Milan 150
Munich 146
Lauterbourg 143
Helsinki 139
Boardman 122
Shanghai 116
Council Bluffs 98
São Paulo 94
San Diego 91
The Dalles 86
Addison 81
Dearborn 81
Buffalo 70
Mexico City 68
Orem 68
Nanchang 67
Turku 66
Shenyang 63
London 62
Jakarta 61
Bremen 59
Brooklyn 59
Brussels 57
Tianjin 52
Chicago 51
Montreal 51
Jiaxing 50
Changsha 47
Hebei 46
Chennai 45
Atlanta 43
Hefei 43
Denver 42
Da Nang 41
Stockholm 41
Johannesburg 38
Norwalk 38
Poplar 38
Vienna 35
Haiphong 34
Phoenix 34
Toronto 33
Falls Church 32
San Francisco 32
Baghdad 30
Manchester 30
Amsterdam 29
Brno 29
Frankfurt am Main 29
Rio de Janeiro 29
San Mateo 28
Boston 27
Ankara 26
Ningbo 26
Guangzhou 25
Zhengzhou 25
Jinan 24
Nuremberg 24
Rome 24
Tashkent 24
Bologna 23
Columbus 23
Moscow 23
Orange 23
Redwood City 23
Biên Hòa 22
Auburn Hills 21
Falkenstein 21
Hải Dương 21
Brasília 19
Kunming 19
Curitiba 18
Mountain View 18
Mumbai 18
Totale 19.123
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 412
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 273
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 261
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 252
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 250
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 248
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 248
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 247
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 243
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 242
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 240
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 237
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 235
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 235
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 230
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 230
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 225
HLA-G Molecules in Autoimmune Diseases and Infections 224
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 223
Emerging topics and new perspectives on HLA-G 221
Survival prediction in high-grade gliomas using CT perfusion imaging 220
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 214
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 214
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 213
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 213
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 210
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 210
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 208
Leptin/adiponectin ratio predicts post-stroke neurological outcome 207
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 204
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 204
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 204
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 203
Cerebrospinal fluid analysis and the determination of oligoclonal bands 201
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 197
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 196
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 194
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 193
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 191
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 188
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 187
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 187
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 186
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 185
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 183
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 183
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 183
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 183
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 182
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 182
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 181
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 181
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 179
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 178
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 177
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 177
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 176
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 176
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 175
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 174
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 172
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 172
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 171
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 169
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 169
Some basic aspects of HLA-G biology. 168
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 168
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 168
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 165
Role of Toll-like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection 164
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 164
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 162
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 162
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 161
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 160
Neurofilament ELISA validation 159
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 157
Le catene leggere libere liquorale sclerosi multipla 156
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 156
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 153
New insights into HLA-G and inflammatory diseases 152
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 150
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 150
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 149
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 149
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 149
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 148
Endovascular Thrombectomy for Acute Ischemic Stroke beyond 6 Hours from Onset: A Real-World Experience 148
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 146
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 145
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 145
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 144
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 143
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 143
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 142
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 141
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 140
An unusual cause of a common symptom: Pyomyositis presenting with sciatica 140
Congruence between clinical diagnosis and DATSCAN imaging in 150 consecutive patients. 140
Sex-Related Differences in Cerebrospinal Fluid Plasma-Derived Proteins of Neurological Patients 137
Totale 18.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.109
Totale 125.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021411 0 0 0 0 0 0 0 0 0 0 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20254.035 103 92 310 158 530 353 98 156 767 477 567 424
2025/202610.797 1.131 456 853 1.429 1.707 771 1.458 620 1.033 1.138 201 0
Totale 28.252